Abstract
Standard intracavitary vaginal brachytherapy devices are limited in the ability to deliver radiation dosage to the upper/apical vagina. Our institution modified the commercially available MIAMI™ applicator (Mick Radio Nuclear Instruments, New York, NY, USA) to allow for extension of needles through seven channels (one central and six peripheral) into the proximal vaginal cuff. This study examines the outcome of brachytherapy using this device through evaluation of acute/chronic toxicities, dosages to organs-at-risk, and tumor control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
